We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Antibodies – News and Features

News

Vaccinex Announces Antibody Collaboration with Schering

Vaccinex will potentially develop therapeutic antibodies for the treatment of certain cancers.
News

Medarex and Organon Announce Antibody Development Agreement

Organon uses Medarex's UltiMAb Human Antibody Development System® for the discovery of fully human antibodies.
News

Protein Design Labs Becomes PDL BioPharma

Protein Design Labs has changed the name to better reflect its status as a commercial company.
News

Xencor and Roche Extend XmAb™ Antibody Therapeutics Collaboration

Roche and Xencor entered into this collaboration in January 2005, in which Roche applies Xencor's XmAb Fc domains.
News

Symphogen’s Success Attracts USD 25 Million Investment

The financing will be used to carry out clinical trials of Symphogen’s first product, anti-RhD.
News

Morphotek Divests Cell Evolution Service Business to Invitrogen

This divestment allows Morphotek to focus its business strategy on advancing its therapeutic antibody pipeline.
News

CoGenesys Licenses Intellectual Property Rights for Target Antigen to PDL

PDL will provide CoGenesys with access to its antibody humanization technology platform.
News

PDL Grants Patent Licenses to Merck for Humanized Antibodies

The licensing of humanized antibody technology will build a commercial operation focused on the acute care hospital setting.
News

Morphotek Expands Oncology Pipeline with Product Candidate from NCI

Morphotek is applying its antibody technologies to develop and optimize antibodies to cancer-associated proteins.
News

Acceptys and OncoMab Announce Integration of Human Antibody Drug Development Pipeline and Operations

Acceptys has acquired the right to develop all 8 lead antibody therapeutic candidates from the OncoMab pipeline.
Advertisement